You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
恆指午後跌幅擴至近600點考驗25,600關 舜宇及國壽吐逾5%-6%
阿思達克 07-10 13:42
全球多國疫情急彈,尤其是美股新增病例超過6萬宗再創單日新高,市場憂慮限制措施再度收緊阻礙經濟復甦。美股期貨跌幅擴大,道指期貨跌幅擴至233點或0.9%報25,339;韓股及滬指吐逾1%。

消息指本港今天至少再有30宗確認病例,加上中美關係持續緊張。恆指午後跌幅擴至590點或2.2%,報25,620,成交額1,332億元。

藍籌股除向母企悉售3間附屬涉近8.4億人民幣的吉利(00175.HK)及中生製藥(01177.HK)逆升2%及1.2%分別報17.28元及15.08元外,無一倖免,跌幅普遍逾1%-2%,其中重磅股匯控(00005.HK)、建行(00939.HK)、中移動(00941.HK)、友邦(01299.HK)及騰訊(00700.HK)跌1.8%-2.8%,後兩者最傷分別低見74.2元及546元。

萬洲(00288.HK)、聯通(00762.HK)、貼價走低的中石油(00857.HK)、舜宇(02382.HK)及國壽(02628.HK)更挫4%-6.4%,後兩者最傷分別報139.9元及19.56元,急吐逾5%-6%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account